Neurotrophic factors in Alzheimer's and Parkinson's diseases: implications for pathogenesis and therapy

TB Sampaio, AS Savall, MEZ Gutierrez… - Neural regeneration …, 2017 - journals.lww.com
Neurotrophic factors comprise essential secreted proteins that have several functions in
neural and non-neural tissues, mediating the development, survival and maintenance of …

Exercise-induced neuroprotection of the nigrostriatal dopamine system in Parkinson's disease

L Hou, W Chen, X Liu, D Qiao, FM Zhou - Frontiers in aging …, 2017 - frontiersin.org
Epidemiological studies indicate that physical activity and exercise may reduce the risk of
developing Parkinson's disease (PD), and clinical observations suggest that physical …

Event‐related beta desynchronization in human subthalamic nucleus correlates with motor performance

AA Kühn, D Williams, A Kupsch, P Limousin, M Hariz… - Brain, 2004 - academic.oup.com
Although the basal ganglia play an important role in self‐generated movement, their
involvement in externally paced voluntary movement is less clear. We recorded local field …

Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the …

D Kirik, C Rosenblad, A Björklund… - Journal of …, 2000 - Soc Neuroscience
Previous studies have used recombinant adeno-associated viral (rAAV) vectors to deliver
glial cell line-derived neurotrophic factor (GDNF) in the substantia nigra to protect the nigral …

Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain

NB Chauhan, GJ Siegel, JM Lee - Journal of chemical neuroanatomy, 2001 - Elsevier
The distribution of nerve growth factor (NGF), ciliary neurotrophic factor (CNTF), glial cell line-
derived neurotrophic factor (GDNF), brain derived neurotrophic factor (BDNF), neurotrophin …

Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease

A Björklund, C Rosenblad, C Winkler, D Kirik - Neurobiology of disease, 1997 - Elsevier
Intrastriatal 6-hydroxydopamine injections in rats induce partial lesions of the nigrostriatal
dopamine (DA) system which are accompanied by a delayed and protracted degeneration …

Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum …

C Rosenblad, D Kirik, B Devaux… - European Journal of …, 1999 - Wiley Online Library
Both glial cell line‐derived neurotrophic factor (GDNF) and its recently discovered congener,
neurturin (NTN), have been shown to excert neuroprotective effects on lesioned nigral …

Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces …

A Eslamboli, B Georgievska, RM Ridley… - Journal of …, 2005 - Soc Neuroscience
The therapeutic potential of glial cell line-derived neurotrophic factor (GDNF) for Parkinson's
disease is likely to depend on sustained delivery of the appropriate amount to the target …

Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6‐OHDA lesion model depends on the site of administration of the trophic …

D Kirik, C Rosenblad… - European Journal of …, 2000 - Wiley Online Library
Here we studied whether glial cell line‐derived neurotrophic factor (GDNF), given as a
single bolus injection before an intrastriatal 6‐hydroxydopamine (6‐OHDA) lesion, can …

Role for GDNF in biochemical and behavioral adaptations to drugs of abuse

CJ Messer, AJ Eisch, WA Carlezon, K Whisler, L Shen… - Neuron, 2000 - cell.com
The present study examined a role for GDNF in adaptations to drugs of abuse. Infusion of
GDNF into the ventral tegmental area (VTA), a dopaminergic brain region important for …